Cover Image
Market Research Report
Product code
1003408

Neurovascular Devices Market Size, Share & Trends Analysis Report By Device, By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm), By Region, And Segment Forecasts, 2021 - 2028

Published: | Grand View Research, Inc. | 120 Pages | Delivery time: 2-10 business days

Price

Back to Top
Neurovascular Devices Market Size, Share & Trends Analysis Report By Device, By Therapeutic Application (Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm), By Region, And Segment Forecasts, 2021 - 2028
Published: April 27, 2021
Grand View Research, Inc.
Content info: 120 Pages
Delivery time: 2-10 business days
  • ALL
  • Description
  • Table of Contents
Description

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 4.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2021 to 2028. Increasing incidence of neurological disorders such as stroke, brain aneurysm, cerebral artery stenosis, are fueling the market growth. For instance, the Stroke Association states, more than 100,000 people suffer from stroke every year in the U.K. Thereby, the numbers reveal the high demand for neurovascular equipment, thus leading to market growth.

Decreased postoperative pain, a speedy recovery is leading to increasing adoption of minimally invasive surgeries and triggering the growth of R&D in this field. The endovascular coiling used for the treatment of intracranial aneurysm is one of the minimally invasive procedures and is widely recommended by physicians. As compared to the bare-platinum coils, HydroCoils (MicroVention, Tustin, California, USA) has enabled the treatment of more complex aneurysmal structures with lower recurrence rates. Thus, the rising demand for minimally invasive procedures is further fueling the market growth.

Patients suffering from Covid-19 have subsequently exhibited neurologic symptoms that are expected to create a favorable environment for market growth. For instance, as per the study in Lancet, 1 in 3 COVID patients who recovered have neurological and mental health disorders. The study was led by Oxford University researchers and included over 2 lakh COVID patients who recovered from the disease. Such instances will surge the demand for neurovascular equipment. Thus, COVID-19 might have a positive impact on the market in the coming years.

Neurovascular Devices Market Report Highlights

The cerebral embolization and aneurysm coiling devices segment dominated the market in 2020 due to soaring incidence of cerebral artery stenosis, increase in the number of technologically advanced product launches by key players and surge in R&D

Based on therapeutic application, the stroke segment dominated the market in 2020 due to escalating prevalence of stroke globally and the launch of technologically advanced products by the market players

North America led the market with the maximum revenue share in 2020 owing to the rising prevalence of stroke and brain aneurysm, growing disposable income, and presence of major players in the region

Table of Contents
Product Code: GVR-2-68038-851-0

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Device
    • 1.1.2 Therapeutic Application
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Neurovascular Devices Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Regulatory Framework
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increasing Prevalence Of Brain Aneurysm
      • 3.4.1.2 Introduction Of Technologically Advanced Products
      • 3.4.1.3 Rising Adoption Of Unhealthy Lifestyle
      • 3.4.1.4 Increasing Number Of Awareness Initiatives Worldwide
      • 3.4.1.5 Increasing Demand For Minimally Invasive Procedures
    • 3.4.2 Market Restraints Analysis
      • 3.4.2.1 Stringent And Complex Regulatory Framework
      • 3.4.2.2 High Cost Of Treatment
  • 3.5 Neurovascular Devices: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
    • 3.5.2 Swot Analysis, By Pestle

Chapter 4 Neurovascular Devices Market: Segment Analysis, By Device, 2016 - 2027 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Device Market Share Analysis, 2020 & 2028
  • 4.3 Global Neurovascular Devices Market, by Device, 2016 to 2028
  • 4.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028
    • 4.4.1 Cerebral Embolization And Aneurysm Coiling Devices
      • 4.4.1.1 Cerebral Embolization And Aneurysm Coiling Devices Market, 2016 - 2028 (USD Million)
      • 4.4.1.2 Embolic Coils
      • 4.4.1.2.1 Embolic Coils Market, 2016 - 2028 (USD Million)
      • 4.4.1.3 Flow Diversion Devices
      • 4.4.1.3.1 Flow Diversion Devices Market, 2016 - 2028 (USD Million)
      • 4.4.1.4 Liquid Embolic Agents
      • 4.4.1.4.1 Liquid Embolic Agents Market, 2016 - 2028 (USD Million)
    • 4.4.2 Cerebral Angioplasty And Stenting Systems
      • 4.4.2.1 Cerebral angioplasty and stenting systems market, 2016 - 2028 (USD Million)
      • 4.4.2.2 Carotid Artery stents
      • 4.4.2.2.1 Carotid Artery stents market, 2016 - 2028 (USD Million)
      • 4.4.2.3 Embolic Protection Devices
      • 4.4.2.3.1 Embolic protection devices market, 2016 - 2028 (USD Million)
    • 4.4.3 Neurothrombectomy Devices
      • 4.4.3.1 Neurothrombectomy devices market, 2016 - 2028 (USD Million)
      • 4.4.3.2 Clot retrieval devices
      • 4.4.3.2.1 Clot retrieval devices market, 2016 - 2028 (USD Million)
      • 4.4.3.3 Suction devices
      • 4.4.3.3.1 Suction devices market, 2016 - 2028 (USD Million)
      • 4.4.3.4 Vascular snares
      • 4.4.3.4.1 vascular snares market, 2016 - 2028 (USD Million)
    • 4.4.4 Support Devices
      • 4.4.4.1 Support Devices market, 2016 - 2028 (USD Million)
      • 4.4.4.2 Micro Catheters
      • 4.4.4.2.1 Micro Catheters market, 2016 - 2028 (USD Million)
      • 4.4.4.3 Micro guidewires
      • 4.4.4.3.1 Micro guidewires market, 2016 - 2028 (USD Million)

Chapter 5 Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2016 - 2028 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Therapeutic Applications Market Share Analysis, 2019 & 2028
  • 5.3 Global Neurovascular Devices Market, by Therapeutic Applications, 2016 to 2028
  • 5.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028
    • 5.4.1 STROKE
      • 5.4.1.1 Stroke market, 2016 - 2028 (USD Million)
    • 5.4.2 Cerebral Artery Stenosis
      • 5.4.2.1 Cerebral artery stenosis market, 2016 - 2028 (USD Million)
    • 5.4.3 Cerebral Aneurysm
      • 5.4.3.1 Cerebral aneurysm market, 2016 - 2028 (USD Million)
      • 5.4.3.2 Aneurysmal subarachnoid hemorrhage market, 2016 - 2028 (USD Million)
      • 5.4.3.2.1 Aneurysmal subarachnoid hemorrhage market, 2016 - 2028 (USD Million)
      • 5.4.3.3 Others market, 2016 - 2028 (USD Million)
      • 5.4.3.3.1 Others market, 2016 - 2028 (USD Million)
    • 5.4.4 Others
      • 5.4.4.1 Others market, 2016 - 2028 (USD Million)

Chapter 6 Neurovascular Devices Market: Regional Market Analysis, By Device Type, Therapeutic Application, 2016 - 2028 (USD Million)

  • 6.1 Definition & Scope
  • 6.2 Regional Market Share Analysis, 2020 & 2028
  • 6.3 Regional Market Snapshot
  • 6.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Latin America
    • 6.4.5 Middle East And Africa
  • 6.5 Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2028
  • 6.6 North America
    • 6.6.1 North America Neurovascular Devices Market, 2016 - 2028 (USD Million)
    • 6.6.2 U.S.
      • 6.6.2.1 U.S. Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.6.3 Canada
      • 6.6.3.1 Canada Neurovascular Devices market, 2016 - 2028 (USD Million)
  • 6.7 Europe
    • 6.7.1 EuropeNeurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.2 U.K.
      • 6.7.2.1 U.K. Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.3 Germany
      • 6.7.3.1 Germany Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.4 France
      • 6.7.4.1 France Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.5 Italy
      • 6.7.5.1 Italy Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.6 Spain
      • 6.7.6.1 Spain Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.7 Asia Pacific
    • 6.7.8 Asia Pacific neurovascular devices market, 2016 - 2028 (USD Million)
    • 6.7.9 Japan
      • 6.7.9.1 Japan Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.10 China (Mainland)
      • 6.7.10.1 China (Mainland) Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.11 India
      • 6.7.11.1 India Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.12 Australia
      • 6.7.12.1 Australia Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.7.13 South Korea
      • 6.7.13.1 South Korea Neurovascular Devices market, 2016 - 2028 (USD Million)
  • 6.8 Latin America
    • 6.8.1 Latin America neurovascular devices market, 2016 - 2028 (USD Million)
    • 6.8.2 Brazil
      • 6.8.2.1 Brazil Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.8.3 Mexico
      • 6.8.3.1 Mexico Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.8.4 Argentina
      • 6.8.4.1 Argentina Neurovascular Devices market, 2016 - 2028 (USD Million)
  • 6.9 MEA
    • 6.9.1 MEA neurovascular devices market, 2016 - 2028 (USD Million)
    • 6.9.2 South Africa
      • 6.9.2.1 South Africa Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.9.3 Saudi Arabia
      • 6.9.3.1 Saudi Arabia Neurovascular Devices market, 2016 - 2028 (USD Million)
    • 6.9.4 UAE
      • 6.9.4.1 UAE Neurovascular Devices market, 2016 - 2028 (USD Million)

Chapter 7 Neurovascular Devices Market - Competitive Analysis

  • 7.1 Company Profiles
    • 7.1.1 MEDTRONIC
      • 7.1.1.1 Company overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Product benchmarking
      • 7.1.1.4 Strategic initiatives
    • 7.1.2 MICROPORT SCIENTIFIC CORPORATION
      • 7.1.2.1 Company overview
      • 7.1.2.2 Financial Performance
      • 7.1.2.3 Product/Service benchmarking
      • 7.1.2.4 Strategic initiatives
    • 7.1.3 PENUMBRA, INC.
      • 7.1.3.1 Company overview
      • 7.1.3.2 Financial performance
      • 7.1.3.3 Product/Service benchmarking
      • 7.1.3.4 Strategic initiatives
    • 7.1.4 STRYKER
      • 7.1.4.1 Company overview
      • 7.1.4.2 Financial performance
      • 7.1.4.3 Product benchmarking
      • 7.1.4.4 Strategic initiatives
    • 7.1.5 JOHNSON AND JOHNSON SERVICES, INC.
      • 7.1.5.1 Company overview
      • 7.1.5.2 Financial performance
      • 7.1.5.3 Product benchmarking
      • 7.1.5.4 Strategic initiatives
    • 7.1.6 MICROVENTION INC. (TERUMO CORPORATION)
      • 7.1.6.1 Company overview
      • 7.1.6.2 Financial performance
      • 7.1.6.3 Product benchmarking
      • 7.1.6.4 Strategic initiatives
    • 7.1.7 CODMAN NEURO (INTEGRA LIFESCIENCES CORPORATION)
      • 7.1.7.1 Company overview
      • 7.1.7.2 Financial performance
      • 7.1.7.3 Product benchmarking
      • 7.1.7.4 Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America neurovascular devices market, by country, 2016 - 2028 (USD Million)
  • Table 4. North America neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 5. North America neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Billion)
  • Table 6. U.S. neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 7. U.S. neurovascular devices, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 8. Canada neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 9. Canada neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 10. Europe neurovascular devices market, by country, 2016 - 2028 (USD Million)
  • Table 11. Europe neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 12. Europe neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 13. U.K. neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 14. U.K. neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 15. Germany neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 16. Germany neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 17. France neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 18. France neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 19. Italy neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 20. Italy neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 21. Spain neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 22. Spain neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 23. Asia Pacific neurovascular devices market, by country, 2016 - 2028 (USD Million)
  • Table 24. Asia Pacific neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 25. Asia Pacific neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 26. China neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 27. China neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 28. Japan neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 29. Japan neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 30. India neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 31. India neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 32. Australia neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 33. Australia neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 34. South Korea neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 35. South Korea neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 36. Latin America neurovascular devices market, by country, 2016 - 2028 (USD Million)
  • Table 37. Latin America neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 38. Latin America neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 39. Brazil neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 40. Brazil neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 41. Mexico neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 42. Mexico neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 43. Argentina neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 44. Argentina neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 45. Middle East & Africa neurovascular devices market, by country, 2016 - 2028 (USD Million)
  • Table 46. Middle East & Africa neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 47. Middle East & Africa neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 48. South Africa neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 49. South Africa neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 50. Saudi Arabia neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 51. Saudi Arabia neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)
  • Table 52. UAE neurovascular devices market, by device, 2016 - 2028 (USD Million)
  • Table 53. UAE neurovascular devices market, by therapeutic application, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Neurovascular devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2019)
  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Neurovascular devices market: Device movement analysis
  • Fig. 18 Neurovascular devices market device outlook: Key takeaways
  • Fig. 19 Cerebral embolization and aneurysm coiling devices market, 2016 - 2028 (USD Million)
  • Fig. 20 Embolic coils market, 2016 - 2028 (USD Million)
  • Fig. 21 Flow diversion devices market, 2016 - 2028 (USD Million)
  • Fig. 22 Liquid embolic agents market, 2016 - 2028 (USD Million)
  • Fig. 23 Cerebral angioplasty and stenting systems market, 2016 - 2028 (USD Million)
  • Fig. 24 Carotid artery stents market, 2016 - 2028 (USD Million)
  • Fig. 25 Embolic protection devices market, 2016 - 2028 (USD Million)
  • Fig. 26 Neurothrombectomy devices market, 2016 - 2028 (USD Million)
  • Fig. 27 Clot retrieval devices market, 2016 - 2028 (USD Million)
  • Fig. 28 Suction devices market, 2016 - 2028 (USD Million)
  • Fig. 29 Vascular snares market, 2016 - 2028 (USD Million)
  • Fig. 30 Support devices market, 2016 - 2028 (USD Million)
  • Fig. 31 Micro catheters market, 2016 - 2028 (USD Million)
  • Fig. 32 Micro guidewires market, 2016 - 2028 (USD Million)
  • Fig. 33 Neurovascular devices market: Therapeutic application movement analysis
  • Fig. 34 Neurovascular devices market therapeutic applications outlook: Key takeaways
  • Fig. 35 Stroke market, 2016 - 2028 (USD Million)
  • Fig. 36 Cerebral artery stenosis market, 2016 - 2028 (USD Million)
  • Fig. 37 Cerebral aneurysm market, 2016 - 2028 (USD Million)
  • Fig. 38 Others market, 2016 - 2028 (USD Million)
  • Fig. 39 Regional outlook, 2019 & 2027
  • Fig. 40 Regional market place: Key takeaways
  • Fig. 41 North America, SWOT, by PESTLE
  • Fig. 42 Europe, SWOT, by PESTLE
  • Fig. 43 Asia Pacific, SWOT, by PESTLE
  • Fig. 44 Latin America, SWOT, by PESTLE
  • Fig. 45 Middle East and Africa, SWOT, by PESTLE
  • Fig. 46 North America neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 47 U.S. neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 48 Canada neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 49 Europe neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 50 U.K. neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 51 Germany neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 52 France neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 53 Italy neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 54 Spain neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 55 Asia Pacific neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 56 Japan neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 57 China (Mainland) neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 58 India neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 59 Australia neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 60 South Korea neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 61 Latin America neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 62 Brazil neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 63 Mexico neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 64 Argentina neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 65 MEA neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 66 South Africa neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 67 Saudi Arabia neurovascular devices market, 2016 - 2028 (USD Million)
  • Fig. 68 UAE neurovascular devices market, 2016 - 2028 (USD Million)